A. Kalogeridis

Cytokine mRNA expression in hepatitis C virus infection: TH1 predominance in patients with chronic hepatitis C and TH1–TH2 cytokine profile in subjects with self‐limited disease

M. Raptopoulou-Gigi, E. Vrettou, E. Gigi, 2007, Journal of viral hepatitis.

Altered sialyl- and fucosyl-linkage on mucins in cystic fibrosis patients promotes formation of the sialyl-Lewis X determinant on salivary MUC-5B and MUC-7

M. Hodson, H. Kariyawasam, A. Kalogeridis, 2001, Pflügers Archiv.

Association between BBS6/MKKS gene polymorphisms, obesity and metabolic syndrome in the Greek population

A. Kouvatsi, A. Tsapas, K. Paletas, 2008, International Journal of Obesity.

Sulphation of the salivary mucin MG1 (MUC-5B) is not correlated to the degree of its sialylation and is unaffected by cystic fibrosis

M. Hodson, H. Kariyawasam, A. Kalogeridis, 2001, Pflügers Archiv.

Absence of JAK2V617F mutation in patients with beta-thalassemia major and thrombocytosis due to splenectomy

E. Vlachaki, A. Kalogeridis, F. Klonizakis, 2012, Molecular Biology Reports.

Cardiomyogenic potential of human adult bone marrow mesenchymal stem cells in vitro.

A. Kalogeridis, P. Antonitsis, C. Papakonstantinou, 2008, The Thoracic and cardiovascular surgeon.

First identification of VIM-1-producing Citrobacter freundii in Greece.

E. Protonotariou, D. Sofianou, A. Kalogeridis, 2008, International journal of antimicrobial agents.

Soluble triggering receptor expressed on myelocytes-1 compared to procalcitonin in patients with infectious and autoimmune systemic inflammatory response syndrome.

P. Boura, A. Kalogeridis, I. Gkougkourelas, 2016, Hippokratia.